623P KEYNOTE-199 phase II study of pembrolizumab plus enzalutamide for enzalutamide-resistant metastatic castration-resistant prostate cancer (mCRPC): Cohorts (C) 4 and 5 update

Conference Paper

Full Text

Published version (via Digital Object Identifier)

Duke Authors

Hoimes, Christopher

Cited Authors

Omlin, AG; Graff, JN; Hoimes, CJ; Tagawa, ST; Hwang, C; Kilari, D; Ten Tije, AJ; McDermott, R; Vaishampayan, UN; Elliott, T; Gerritsen, WR; Wu, H; Kim, J; Schloss, C; de Bono, JS; Antonarakis, ES

Published Date

September 2020

Published In

Annals of Oncology

Volume / Issue

31 /

Start / End Page

S514 - S515

Published By

Elsevier BV

International Standard Serial Number (ISSN)

0923-7534

Digital Object Identifier (DOI)

10.1016/j.annonc.2020.08.882